about
FAAH inhibitors in the limelight, but regrettablyCa(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamolFatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brainMonoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia.Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context.Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic SystemDiabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms[Paracetamol: a promising ancestor]A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptorParacetamol is a centrally acting analgesic using mechanisms located in the periaqueductal greyInhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammationThe Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells
P50
Q28067151-B1AF106D-74B4-43D6-ACCE-F21458049110Q28306254-9C342033-E912-44DA-8BE2-7D8123FDFD67Q28535122-6B0EB53C-0DBA-493E-9ECE-B1B4F4702B07Q28535638-19DF284F-9A79-44F2-98F1-09045BDFA718Q34779104-25CC8AF5-D348-4B7E-8505-1C978F1F06E4Q37517378-67B633B2-61C5-457B-A0A1-D19C585C444BQ48436115-A4164737-2896-41D2-92B5-C78AE2C9424BQ53981640-C9C5E625-672F-482D-BD11-E00C1384430EQ63384591-3CDC4C81-0F7C-416F-8922-01704457B291Q79988725-5F28F50A-6080-44BA-B768-448F9BB8B160Q85316296-79737CA4-FAE9-43C1-ABDB-26EF7E11B840Q90702264-A52B2721-830A-4BC6-BADD-B499E259FA3BQ91309854-6269778E-0C59-47AA-80BD-267A5FF65FB5Q91325263-CB865D71-25C8-4EF9-87EC-5B6A597554C9Q92815340-A8D60659-FD6D-4155-B71B-3C197A211BBA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Christophe Mallet
@en
Christophe Mallet
@nl
type
label
Christophe Mallet
@en
Christophe Mallet
@nl
prefLabel
Christophe Mallet
@en
Christophe Mallet
@nl
P31
P496
0000-0002-0873-6763